AMANDA VAN WYK: Open Payments
NPI 1558673095 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,772 in 75 payments from 17 companies in 2025. Trend: 2023 $1,425 · 2024 $1,643 · 2025 $1,772
Food & beverage: $1,673Education: $99
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $449 |
| Janssen Biotech, Inc. | 14 | $303 |
| Novartis Pharmaceuticals Corporation | 6 | $178 |
| Amgen Inc. | 12 | $157 |
| E.R. Squibb & Sons, L.L.C. | 5 | $98 |
| PFIZER INC. | 1 | $94 |
| ABBVIE INC. | 4 | $83 |
| Lilly USA, LLC | 3 | $71 |
| Organon LLC | 6 | $62 |
| Galderma Laboratories, L.P. | 3 | $56 |
Products named: Bimzelx, TREMFYA, OTEZLA, Sotyktu, LITFULO, COSENTYX, TALTZ, SKYRIZI.
Industry payments across IA — which companies pay providers there.
